Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-term renal transplant recipients

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-term renal transplant recipients

Background: Malignancy is a major cause of morbidity and mortality in transplant recipients. Identification of those at highest risk could facilitate pre-emptive intervention such as reduction of immunosuppression. Reduced circulating monocytic HLA-DR density is a marker of immune depression in the...

Bibliografski detalji
Glavni autori:	Bottomley, MJ, Harden, PN, Wood, KJ, Hester, J, Issa, F
Format:	Journal article
Jezik:	English
Izdano:	Frontiers Media SA 2022

Slični predmeti

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
od: Bottomley, M, i dr.
Izdano: (2022)

Seborrheic keratoses are a further marker of cutaneous malignancy in renal transplant recipients independent of sun exposure
od: Lally, A, i dr.
Izdano: (2006)

Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.
od: Bottomley, M, i dr.
Izdano: (2016)

Prevalence of nonmalignant cutaneous disease in renal transplant recipients
od: Lally, A, i dr.
Izdano: (2006)

Update on the long-term complications of renal transplantation.
od: Bottomley, M, i dr.
Izdano: (2013)

The accuracy of clinical diagnosis of suspected premalignant and malignant skin lesions in renal transplant recipients.
od: Cooper, S, i dr.
Izdano: (2002)

Melanomas in renal transplant recipients.
od: Le Mire, L, i dr.
Izdano: (2006)

Seborrhoeic dermatitis in renal transplant recipients
od: Lary, A, i dr.
Izdano: (2007)

Gout in pediatric renal transplant recipients.
od: Trück, J, i dr.
Izdano: (2010)

Skin cancers in renal transplant recipients
od: Bordea, C
Izdano: (2001)

Malignancies after renal transplantation
od: Bastiaannet, E, i dr.
Izdano: (2010)

The utilisation of biomarkers of a reduced immune response to predict squamous cell carcinoma in long-term renal transplant recipients
od: Bottomley, M
Izdano: (2015)

Steroid withdrawal or avoidance in renal transplant recipients
od: Chang, S.H., i dr.
Izdano: (2006)

Lymphoproliferative disorders in Oxford renal transplant recipients.
od: Bates, W, i dr.
Izdano: (2003)

Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
od: Currie, A, i dr.
Izdano: (2010)

Increased incidence of melanoma in renal transplant recipients
od: Imko-Walczuk, B, i dr.
Izdano: (2006)

Hypertrophic pseudofolliculitis in white renal transplant recipients.
od: Lally, A, i dr.
Izdano: (2007)

Determinants of insulin resistance in renal transplant recipients.
od: Oterdoom, L, i dr.
Izdano: (2007)

Complement and renal transplantation: from donor to recipient.
od: Damman, J, i dr.
Izdano: (2008)

Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplants.
od: Rosenberg, WM, i dr.
Izdano: (1992)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
od: Carroll, R, i dr.
Izdano: (2013)

Inflammatory Ly-6Chi monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients
od: Schiopu, A, i dr.
Izdano: (2012)

Urological malignancy after renal transplantation.
od: Besarani, D, i dr.
Izdano: (2007)

Point prevalence of cutaneous disease in renal transplant recipients
od: Lally, A, i dr.
Izdano: (2006)

Clinical characteristics of renal transplant recipients with viral warts
od: Lally, A, i dr.
Izdano: (2008)

Lymphomas in renal transplant recipients: a search for clustering.
od: Kinlen, L, i dr.
Izdano: (1979)

Hypertrophic pseudofolliculitis barbae in Caucasian renal transplant recipients
od: Lally, A, i dr.
Izdano: (2006)

Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.
od: Schiopu, A, i dr.
Izdano: (2012)

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation
od: Brook, MO, i dr.
Izdano: (2024)

Urinary Tract Infection among Renal Transplant Recipients in Yemen
od: Gondos, A.S., i dr.
Izdano: (2015)

Hymenolepis nana in a renal transplant recipient : to treat or not to treat?
od: Amin Nordin, Syafinaz, i dr.
Izdano: (2011)

Erythema nodosum-like lesions in a renal transplant recipient.
od: Yap, Felix Boon Bin, i dr.
Izdano: (2011)

Hyperparathyroidism, hypertension and loop diuretic medication in renal transplant recipients.
od: Bittar, A, i dr.
Izdano: (1989)

TET1 is a tumor suppressor of hematopoietic malignancy
od: Cimmino, Luisa, i dr.
Izdano: (2017)

Pregnancy in renal transplant recipients: a UK national cohort study.
od: Bramham, K, i dr.
Izdano: (2013)

The cost of delivering a skin cancer service to renal transplant recipients
od: Lally, A, i dr.
Izdano: (2007)

The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.
od: Bittar, A, i dr.
Izdano: (1990)

Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells
od: Goulart, MR, i dr.
Izdano: (2019)

Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
od: Wright, S, i dr.
Izdano: (2021)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
od: Brook, MO, i dr.
Izdano: (2022)